WFA
ALBO

Wipfli Financial Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Wipfli Financial Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$11K Buy
+564
New +$11.7K ﹤0.01% 1824

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wipfli Financial Advisors's ALBO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Albireo Pharma Inc (ALBO) in Q3 2022: 564 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1824 among its holdings.

108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Wipfli Financial Advisors held 564 shares of Albireo Pharma Inc worth $11K as of Q3 2022.
  • Albireo Pharma Inc was a new Wipfli Financial Advisors position in Q3 2022.
  • Albireo Pharma Inc made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1824 holding.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.